Data Insights Risk adjusted net present value: What is the current valuation of Lineage Cell Therapeutics’s OPC-1?
Data Insights Risk adjusted net present value: What is the current valuation of Orchard Therapeutics’s OTL-201?
Data Insights VIR-1111 by Vir Biotechnology for Human Immunodeficiency Virus (HIV) Infections (AIDS): Likelihood of Approval
Buyer's Guides Pharmaceutical solid dose (commercial dose) manufacturing companies in contract manufacturing